Erratum to “Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice” [J. Dermatol. Sci. 56 (2009) 37–42]
Article Outline
The Author regrets that when this paper was originally published, magnification details in the caption for Figure 1 were incorrect.
Figure 1 plus the correct caption are as follows:

Fig. 1.
Clinical skin features and histological features of the dorsal skin in the control mice and in the mice given oral administration of Yokukansan (YKS) for 12 weeks after the start of treatment. A and D: control; B and E: 0.5% YKS; C and F: 1% YKS. D, E, and F: haematoxylin and eosin staining; Total magnification 100x.
PII: S0923-1811(09)00328-4
doi:10.1016/S0923-1811(09)00328-4
© 2009 Japanese Society for Investigative Dermatology. All rights reserved.
Refers to article:
- Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice Corrected Proof, 12 July 2010
